Expressions of matrix metalloproteinases 1 and 3 and their tissue inhibitors in the conjunctival tissue and fi broblasts cultured from conjunctivochalasis

Min-Hong Xiang1, Xing-Ru Zhang1,2, Zhen-Yong Zhang1, Qing-Song Li1, Han-Min Wang1, Zhu-Mei Han1,Huan-Ming Zhou1, Yuan-Ling Jia1, Xing-Xing Chen1

1Department of Ophthalmology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062,China

2Liqun Hospital, Putuo District, Shanghai 200062, China

Abstract

· AlM: To investigate the expression of matrix metalloproteinases 1 and 3 (MMP-1 and MMP-3) and their tissue inhibitors of metalloproteinases 1 and 3 (TlMP-1 and TlMP-3) in the conjunctiva of eyes with conjunctivochalasis (CCh).

· METHODS: The conjunctival tissue was obtained from the CCh patients and controls, the MMPs/TlMPs expression concentration was determined by enzyme-linked immunosorbent assay (ELlSA) and immunof l uorescence staining.The expression levels of MMPs/TlMPs in the CCh fibroblasts were determined by analyzing its concentration in the cellular supernatant that was abstracted from the in vitro cultured CCh fi broblasts.

· RESULTS: MMP-1 and MMP-3 levels determined by ELlSA were both signi fi cantly higher in the CCh group than that in the control group (P=0.042, 0.022, respectively), so was the levels of TlMP-1 (P=0.010). No significant difference in the expression of TlMP-3 in conjunctiva was found between the two groups (P=0.298). The expression of MMP-1 and MMP-3 were both up-regulated signi fi cantly in the CCh group (P=0.040, 0.001, respectively) on immunofl uorescence staining. MMP-1 and MMP-3 expression in the fi broblasts were both signi fi cantly higher in the CCh group than that in the control group (P=0.027, 0.001, respectively),while neither the TlMP-1 nor TlMP-3 expression was significantly different between the two groups (P=0.421,0.237, respectively).

· CONCLUSlON: The overexpression of MMP-1 and MMP-3 in conjunctival tissue and fi broblasts may play an important role in the pathogenesis and development of CCh.

· KEYWORDS: conjunctivochalasis; relaxed conjunctiva;fi broblast; matrix metalloproteinase; tissue inhibitor of matrix metalloproteinase

INTRODUCTION

Conjunctivochalasis (CCh) is def i ned as redundant, oe- ematous conjunctiva typically located between the eyeball and the lower eyelid. It commonly occurs in the elderly and can cause intermittent epiphora, ocular irritation, and subconjunctival hemorrhage[1-2]. The mechanism behind CCh has yet to be elucidated, as the age-related and inf l ammatory changes and mechanical friction from blinking eyelids have been suggested as risk factors that could incur a change in the bulbar conjunctiva, tear, and eyelid. Inf l ammation is believed to alter the expression of matrix metalloproteinases (MMPs)and tissue inhibitors of metalloproteinases (TIMPs) in the conjunctival fibroblasts[3], which is unpinned by the finding that MMP-9 is significantly reduced after CCh surgery[4].PTX3 and TSG-6 mediate the transcription and activation of MMP-1 and MMP-3 in CCh[5-6]. So MMPs and TIMPs might be the most important enzyme in the pathogenesis of CCh. This study is designed to detect the expression of MMPs and TIMPs in both the conjunctiva and in vitro cultured conjunctival fibroblasts and to further assess the role of MMPs/TIMPs in the pathogenesis of CCh.

SUBJECTS AND METHODS

Subjects Based on the standard described in a previous paper[7],46 subjects (18 males, 28 females; mean age: 72.77±7.42y)with CCh of more than grade II that underwent conjunctival resection surgery were recruited as the CCh group in this study.Twenty-seven eyes of 27 healthy cataract patients without CCh(10 males, 17 females; mean age: 72.25±7.83y) who received phacoemulsif i cation were included as the control group. This study adhered to the Declaration of Helsinki and was approved by the institutional review board. All the included subjects were fully informed of the risks and benef i ts and the consents were signed before proceeding with the examinations and treatments. The subjects who wore contact lenses or who had lid congruity disorders, meibomian gland disease, blepharitis,a history of recent ocular surgery, systemic or topical drug use, or other systemic or eye diseases having an ocular surface presentation were excluded from the study.

Experiment Material The apparatus such as CO2 incubator(SANYO Company, Japan), clean bench (Antai Company,China), inverted microscope (Wilovert Company, Germany),high-speed low-temperature centrifuge (Eppendorf Company,Germany), enzyme-labeled detector (Bio-Rad Company,USA), Dulbecco’s Modified Eagle’s medium (DMEM),mycillin solution, 0.25% trypsin solution (Shanghai Bogoo Biotechnology Company, China); and fibroblast growth supplement (Beijing Yuhengfeng Biotechnology Company,China) were used. The agents like MMP-1, MMP-3, TIMP-1,TIMP-3, and enzyme-linked immunosorbent assay (ELISA)kit (Mingrui Biotech Company, China). MMP-1 antibody and MMP-3 antibody (Abcam, England) were also used.

Conjuctival Tissue Sample Collection The samples of relaxed conjunctiva were collected from the CCh patients undergoing the CCh surgery. Conjunctival resections for CCh were all performed by the same surgeon. The collection of normal control conjunctiva was made in the cataract patients receiving phacoemulsification, the protocol of which was established and described in a previous study[8]. The control samples during cataract surgery were also obtained from the inferior conjunctiva as 3×3-mm samples so that the tissues could be fairly compared.

Experiment Methods

Enzyme-linked immunosorbent assays of conjunctiva Conjunctival specimens were put into sterile test tubes immediately, and buffered salt or saline solution was added to them. Ultrasound breaking at 400 Hz was conducted instantly for 99 times with a time span of 3s. The supernatant was obtained by centrifugation at 12 000 rpm, and then refrigerated at -80℃ for detection.

MMP-1, MMP-3, TIMP-1, and TIMP-3 were prepared as 10 000,5000, 2500, 1250, 625, 312, and 156 pg/mL standard substances. Each standard substance (0.1 mL) was added into seven wells in order and a sample dilution into one well as zero-well to obtain the standard curve. Samples and biotinlabeled antibodies were added into a 96-well ELISA plate in order for reaction, and washed with tris-buffered saline(TBS). Attenuated avidin-peroxidase compound was added for coloration with substrate 3,3',5,5'-tetramethylbenzidine(TMB) after being completely washed with TBS. TMB turned blue under peroxidase catalyst and fi nally to yellow under the action of acid. This color shade is positively related to MMP-1,MMP-3, TIMP-1, and TIMP-3 in the samples. Concentration of all samples can be obtained according to absorbance values and standard curve.

Immunofluorescence staining of conjunctival specimens The excised conjunctival samples were placed in formalin and fi xed for 48h. They were then washed and dehydrated to make it transparent, and later waxed, embedded, then excised for detection.

After dewaxing, the samples were hydrated as follows:dewaxed sections were infiltrated with 100% alcohol, 95%alcohol, 75% alcohol, and double-distilled water, successively,for 3min. Antigen retrieval was conducted by placing the sample in 0.01 mol/L sodium citrate-buffered solution for highpressure repair for 20-30min. During microwave, the sample should be cooled naturally to avoid boiling the solution.The sample was washed with 0.02 mol/L PBS for 5min thrice. Primary antibodies (MMP-1 and MMP-3) diluted in appropriate proportion were dripped as required and incubated under 4℃ overnight. The sample was then rinsed with 0.02 mol/L PBS for 5min thrice with frequent vibration (to remove unnecessary nomadic antibodies). Fluorescent second antibodies diluted in appropriate proportion were dripped and incubated under room temperature for 1h. X-ray was taken with fl uorescence microscope after mounting.

Human fi broblasts cultures The excised bulbar conjunctival tissue was placed in prepared sterile disposable mixing bowl and rinsed with 9 g/L normal saline three times. Then, the tissue was cut with a microscopic ophthalmic scissor into blocks of size 0.5-1 mm2 and laid into a six-well plate, which was then cultured in a CO2 incubator with 5% volume fraction under 37℃ with upside down. When the blocks in the sixwell plate were almost dry, the plate was turned bottom down,and 3-mL DMEM nutrient solution with fetal calf serum and mycillin in 10% volume and 0.1% FGS was added slowly.Adherence and culture condition of inoculated tissue blocks were observed under inverted phase contrast microscope. The positive cell area was calculated to represent the relative value of fl uorescence staining intensity.

Enzyme-linked immunosorbent assays of cultured cellular supernatant Cells of three to six generations in logarithmic growth were selected. After dissociating the cells growing to 90%, DMEM nutrient solution with 10% fetal calf serum was used to prepare cell suspension for inoculation in a 24-well plate at a concentration of 2.5×105 cells/mL with 1 mL per well. After culturing for 24h, the original nutrient solution was abandoned, and 1 mL DMEM nutrient solution without serum was added per well and three complex wells per group.Then, the wells were cultured in the CO2 incubator with 5%volume fraction for 48h under 37℃. The cultured supernatant fluid was collected from each well and centrifuged at a high speed of 1500 rev/rain for 20min. The supernatant was placed in a sterile Eppendorf tube and cryopreserved under -20℃after split charging. The concentrations of MMP-1, MMP-3,TIMP-1, and TIMP-3 were detected using ELISA, and the concentrations of various samples were obtained according to absorbance values and standard curves.

Table 1 ELISA assay of MMPs/TIMPs concentration

aΡ<0.05.

Statistical Analysis The SPSS16.0 software was used for statistical analysis. The average concentration was presented as mean±SD according to the individual concentration calculated from the standard curve and absorbance values. Difference was analyzed using one-way analysis of variance (LSD t-test) and independent-sample t-test if the data were normally distributed while Wilcoxon rank-sum test was used if not. Ρ<0.05 was considered statistically signif i cant.

RESULTS

Enzyme-linked Immunosorbent Assay for Measurement of Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases Levels in Conjunctiva MMP-1 was 489.10±164.49 ng/mL in concentration in the CCh group and 304.17±218.75 ng/mL in the control group with a statistical signif i cance (Ρ=0.042). MMP-3 was 1236.96±1419.53 ng/mL in concentration in the CCh group and 213.79±7.45 ng/mL in the control group with a statistical signif i cance (Ρ=0.022).

TIMP-1 was 1529.92±2147.49 ng/mL in concentration in the CCh group and 93.51±51.20 ng/mL in the control group with a statistical significance (Ρ=0.010). TIMP-3 was 604.60±107.77 ng/mL in concentration in the CCh group and 548.00±154.10 ng/mL in the control group with no statistical signif i cance(Ρ=0.298) (Table 1).

Immunofluorescence for Measurement of Matrix Metalloproteinases Expression in Conjunctiva The positive cells area of MMP-1 was 716.78±39.81 μm2 in the CCh group and 661.50±39.11 μm2 in the control group with a statistical significance (t=2.322, Ρ=0.040). The positive cells area of MMP-3 was 756.56±55.84 μm2 in the CCh group and

620.25±19.82 μm2 in the control group with a great statistical signif i cance (t=4.654, Ρ=0.001) (Table 2; Figure 1).

Table 2 Immunof l uorescence assay of MMPs μm2

Human Fibroblasts Cultures The tissue blocks were closely attached to the 6-well plate after 2-5d of primary culture using the tissue block adherence method. Under an inverted microscope, tissue blocks displayed poor transparence with a dark black area and spilled cells around them. Cell proliferation was observed after 10-15d. The cell rings of the tissue blocks were spread around, in which mosaic-like cells with inhomogeneous morphologies and unclear boundaries were observed. After 20d, the cells grew to above 80% and were used for passage. Pure fi broblast cells could be obtained after two passages (Figure 2). All cells are fiber-like and radially arranged. They have homogenous sizes, long-spindles or biapiculate shapes, an oval nucleus in the plasma, and cell processes with different lengths for cross-linking. And the cells were identif i ed by keratin and vimentin immunof l uorescence staining, vimentin and keratin flow cytometry, which were conf i rmed to be fi broblast cells[9].

Enzyme-linked Immunosorbent Assay for Measurement of Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases Expression in Fibroblasts The MMP-1 levels in fibroblasts were significantly higher in the CCh group(437.62±13.62 ng/mL) than in the control group (404.74±9.68 ng/mL; t=3.408, Ρ=0.027). The MMP-3 levels were significantly higher in the CCh group (0.29±0.02 ng/mL)than in the control group (0.15±0.016 ng/mL; t=8.160,Ρ=0.001). There was no signif i cantly difference in the TIMP-1 concentration between the two groups, nor was in the TIMP-3 concentration (0.48±0.00 ng/mL vs 0.49±0.01 ng/mL, t=-0.896,Ρ=0.421; 0.17±0.01 ng/mL vs 0.15±0.02 ng/mL, t=1.388,Ρ=0.237) (Figure 3).

Figure 1 MMPs of conjunctiva detected with immunof l uorescence staining (×200) A: MMP-1 in the CCh group; B: MMP-1 in the normal control group; C: MMP-3 in the CCh group; D: MMP-3 in the normal control group. Positive expression is marked as green while cell nuclei as blue.

Figure 2 Fibroblast cells from CCh conjunctival tissue of primary culture in vitro A: Primary fibroblast cells from conjunctival tissues with CCh (×100); B: Second-passage fibroblast cells from conjunctival tissue with CCh (×100). All cells are fiber-like and radially arranged. They have homogenous sizes, long-spindles or biapiculate shapes, an oval nucleus in the plasma, and cell processes with different lengths for crosslinking.

Figure 3 MMPs/TIMPs levels in the CCh fibroblasts vs in the normal control using ELISA aΡ<0.05 using independent-sample t-test.

DISCUSSION

The growth in the number of CCh patients have shown to be increasingly fast with the acceleration of population. The incidence of CCh varies in the archives, as Mimura et al[10]have demonstrated that it is 85.24% in the population aged within 1-94y while Zhang et al[11] have reported that it is 44.08% in the population aged 60y or above. The conjunctival fold, a common feature of CCh, is commonly viewed as a senile abnormality[12], which may involve the changes in the extracellular components such as degeneration of elastic fi bers or increased collagenolytic activity, as was evidenced by several pathological studies in which the reduced elastic fi ber and collagen fi bril in lamina propria and fascia tissue of bulbar conjunctiva, the melted collagenous fi ber, and the degenerated fi broblast were found[13-14]. Meller et al[1,3] have suggested that inflammation may initiate the process of collagenous fiber melting, as inf l ammatory reaction-related proteins have shown to appear in tear[15]. As the fi broblast is the most common cell and it secretes many extracellular matrix components including collagenous fi ber and elastic fi ber in the connective tissue, the activity level of which, among others, may feed into the onset and development of CCh.

MMPs are something of protein-cleaving enzymes that can hydrolyze extracellular matrix, among which MMP-1, MMP-2,MMP-3, and MMP-9 are commonly seen in human. MMPs can degrade all components of the extracellular matrix and play an important role in many physiological and pathological processes. TIMPs, which are thought to neutralize the activity of MMPs, also assume a role in maintaining the stability of extracellular matrix. The imbalance between the level of MMPs and TIMPs expression is believed to be closely associated with some ophthalmic diseases such as pterygium, ocular injury,cornea lesion, glaucoma, diabetic retinopathy, and proliferative vitreoretinopathy[16-18]. Overexpression of MMP-1 and MMP-3 in cultured bulbar conjunctival fibroblast was also found in CCh[19].

The present study aimed at further understanding the role of MMPs in the pathogenesis of CCh is therefore designed to detect both of the expression of MMPs and TIMPs in CCh using the method of ELISA and immunofluorescence. To strengthen the performance of this study, inclusion and exclusion criteria were strictly respected and the eligible subjects were recruited.The 3rd to 6th generations of generations of cultured fi broblasts were used for study to avert the inf l uence of the epithelia in the primary culture, as is supported by the fi ndings in a previous paper[9].

An up-regulation of MMP-1 and MMP-3 was observed in both of the conjunctival tissue and fi broblasts of CCh subjects.However, no signif i cant difference was found in the expression levels of TIMPs between the CCh group and control group.

The present study, in which two scientific methods were used, i.e. ELISA and immunofluorescence, has validated the early findings of the overexpression of MMP-1 and MMP-3 in loose conjunctival tissue and fibroblasts in CCh. It is generally accepted that MMP-1 could degrade type I, II, and III collagenase, while MMP-3 has a capacity of degrading type IV, V, VII, and X collagenase, elastic protein, and fi bronectin.The up-regulation of MMPs means its increased activity of melting the collagen fibers and degrading the elastic fibers with a result of over-degradation of conjunctival matrix and Tenon's capsule, thereby thinning the bulbar conjunctiva,resulting in an accumulation of the conjunctiva in the lower eyelid and between inner and lateral canthus, and forming the conjunctival folds. However, additional studies are required to further understand how the expression of MMPs is exactly regulated in the pathogenesis of CCh.

ACKNOWLEDGEMENTS

Foundations: Supported by Shanghai Municipal Health and Family Planning Commission Project (No.20124108);Putuo District of Shanghai Independent Innovation Research Foundation (No.2013PTKW009).

Conflicts of Interest: Xiang HM, None; Zhang XR, None;Zhang ZY, None; Li QS, None; Wang HM, None; Han ZM,None; Zhou HM, None; Jia YL, None; Chen XX, None.

REFERENCES

1 Meller D, Tseng SC. Conjuctivochalasis: literature review and possible pathophysiology. Sur Ophthalmol 1998;43(3):225-232.

2 Zhang XR, Li QS, Xiang MH. Diagnosis and treatment of conjunctivochalasis. Chin J Ophthalmol 2010;46(1):88-91.

3 Meller D, Li DQ, Tseng SC. Regulation of collagenase, stromelysin, and gelatinase B in human conjunctival and conjunctivochalasis fi broblasts by interleukin-lbeta and tumor necrosis factor-alpha. Invest Ophthalmol Vis Sci 2000;41(10):2922-2929.

4 Acera A, Vecino E, Duran JA. Tear MMP-9 levels as a marker of ocular surface inflammation in conjunctivochalasis. Invest Ophthalmol Vis Sci 2013;54(13):8285-8291.

5 Guo P, Zhang SZ, He H, Zhu YT, Tseng SC. PTX3 controls activation of matrix metalloproteinase 1 and apoptosis in conjunctivochalasis fi broblasts. Invest Ophthalmol Vis Sci 2012;3(7):3414-3423.

6 Guo P, Zhang SZ, He H, Zhu YT, Tseng SC. TSG-6 controls transcription and activation of matrix metalloproteinase 1 in conjunctivochalasis. Invest Ophthalmol Vis Sci 2012;53(3):1372-1380.

7 Zhang XR, Zou HD, Li QS, Zhou HM, Liu B, Han ZM, Xiang MH,Zhang ZY, Wang HM. Comparison study of two diagnostic and grading systems for Conjunctivochalasis. Chin Med J (Engl) 2013;126(16):3118-3123.8 Ward SK, Wakamatsu TH, Dogru M, Ibrahim OM, Kaido M, Ogawa Y,Matsumoto Y, Igarashi A, Ishida R, Shimazaki J, Schnider C, Negishi K,Katakami C, Tsubota K. The role of oxidative stress and inf l ammation in conjunctivochalasis. Invest Ophthalmol Vis Sci 2010;51(4):1994-2002.

9 Han ZM, Zhang XR, Zhang L, Ni ZH, Su J, Fu ZX, Li QS, Xiang MH. Culture and identification of conjunctival fibroblast cells in conjunctivochalasis. Ophthalmology CHN 2013;22(2):105-109.

10 Mimura T, Yamagami S, Usui T, Funatsu H, Mimura Y, Noma H,Honda N, Amano S. Changes of conjunctivochalasis with age in a hospital-based study. Am J Ophthalmol 2009;147(1):171-177.e1.

11 Zhang X, Li Q, Zou H, Peng J, Shi C, Zhou H, Zhang G, Xiang M, Li Y. Assessing the severity of conjunctivochalasis in a senile population: a community-based epidemiology study in Shanghai, China. BMC Ρublic Health 2011;11:198.

12 Balci O. Clinical characteristics of patients with conjunctivochalasis.Clin Ophthalmol 2014;8:1655-1660.

13 Li YJ, Zhang XR, Xiang MH, Yu Z, Li QS. Ultrastructure change of conjunctiva and fascia tissue of conjunctivochalasis. Chin J Exp Ophthalmol 2012;30(7):638-640.

14 Mimura T, Usui T, Yamagami S, Funatsu H, Noma H, Honda N,Fukuoka S, Shirakawa R, Hotta H, Amano S. Subconjunctival hemorrhage and conjunctivochalasis. Ophthalmology 2009;16(10):1880-1886.

15 Zhang XR, Xiang MH, Wu QQ, Li QS, Xu Y, Sun AG. The tear protemics analysis of conjunctivochalasis. Speaktrum der Augenheilkund 2008;22(5):288-294.

16 Smith VA, Matthews FJ, Majid MA, Cook SD. Keratoconus: matrix metalloproteinase-2 activation and TIMP modulation. Biochim Biophys Acta 2006;1762(4):431-439.

17 Ashworth Briggs EL, Toh T, Eri R, Hewitt AW, Cook AL. TIMP1,TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients. Mol Vis 2015;21:1162-1172.

18 Di Y, Nie QZ, Chen XL. Matrix metalloproteinase-9 and vascular endothelial growth factor expression change in experimental retinal neovascularization. Int J Ophthalmol 2016;9(6):804-808.

19 Li DQ, Meller D, Liu Y, Tseng SC. Overexpresion of MMP-l and MMP-3 by cultured conjunctivochalasis fibroblasts. Invest Ophthalmol Vis Sci 2000;41(2):404-410.

Correspondence to: Min-Hong Xiang. Department of Ophthalmology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, No. 164, Lanxi Road, Shanghai 200062,China. xiangminhong@sohu.com

Received:2016-04-07

Accepted:2016-10-31

DOl:10.18240/ijo.2017.04.09

Xiang HM, Zhang XR, Zhang ZY, Li QS, Wang HM, Han ZM, Zhou HM, Jia YL, Chen XX. Expressions of matrix metalloproteinases 1 and 3 and their tissue inhibitors in the conjunctival tissue and fibroblasts cultured from conjunctivochalasis. Int J Ophthalmol 2017;10(4):555-559